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tion, which may mimic maternal malnutrition during this period, pro-
grams cardiovascular function and may be involved in development of
chronic diseases.
This study was performed at the Laboratory of Experimental Phar-
macology of Fluminense Federal University and approved by local Ethics
Committee (CEPA/UFF00123-09). Wistar rats were treated with leptin
(PeproTech Inc., London, UK) at a dose of 8 mg/100 g body weight
daily for the ﬁrst 10 days of lactation or saline (Control — Leptin
naïve) as previously described [1,3].
Anthropometrical parameters such as abdominal circumference
(AC)/thoracic circumference (TC) ratio and body mass index (BMI)
were determined in all rats at 30 and 150 days of age [4].
Functional assays were performed with animals at the same age.Experimental studies have shown that hormones and nutrition
status, which affect development during sensitive periods early in life,
permanently program the structure and function of body tissues and
systems [1,2]. Malnutrition in lactating rats could program changes
in leptin action and theoretically affect metabolic rate, changing
leptin serum concentration of the mothers and of their pups [2].
Hyperleptinemia in both the ﬁrst and the last 10 days of lactation was
associated with a higher serum leptin concentration at 150 days of age
and, paradoxically, with a higher food intake and body weight, showing
resistance to the anorectic effect of leptin [1], as observed for those an-
imals programmed by maternal malnutrition during lactation [2] but
the effects were more marked when the leptin was injected within
the ﬁrst 10 days. It was observed that leptin treatment during the ﬁrst
10 days of lactation has a long-term effect on adrenal medullary func-
tion by increasing catecholamine synthesis and secretion, suggesting a
selective leptin resistance in this experimental model and that this
overstimulated sympathoadrenal system could contribute to the devel-
opment of adult chronic diseases [3]. So the aim of the presentworkwasl Pharmacology, Department of
versity, Rua Professor Hernani
EP 24.210-130, Brazil.
etas@gmail.com
.to study if leptin treatment of the pups during the ﬁrst 10 days of lacta-
Systolic blood pressure (SBP) was obtained using tail-cuff method [5].
All electrocardiographic recordings were conducted in awake rats on
derivation DI: heart rate (HR; beats per minute), RR interval (s), QRS
complex (s), PR interval (s) and QT interval (s) [6]. The relationship be-
tween the QT interval and RR interval was individually assessed to ob-
tain physiologically relevant values for the heart rate-corrected QT
interval (QTc): QT / √RR [6]. Echocardiography was performed with
anesthetized rats according to the American Society of Echocardiogra-
phy [7], being acquired: left ventricle ejection fraction (LVEF); intraven-
tricular septum thickness (IVS); left ventricle posterior wall thickness
(LVPW); left ventricle internal diameter (LVID); relative wall thickness
(RWT); left ventriclemass (LVmass) and left-atrium-to-aorta ratio (LA/
Ao ratio), in systole and/or in diastole. Mitral deceleration time (Mitral
DT) was measured using Echo Doppler. Rats were also subjected to a
treadmill exercise test to achieve their maximal effort (distance per-
formed, time spent and speed developed) addressed when rats were
unable to run voluntarily after strenuous exercise [7].
All data are expressed as mean ± SEM. A two-tailed unpaired
Student's t-test was performed and statistical signiﬁcance was accepted
at the 0.05 level (Graph-Pad Prism 5.0).
Table 1 shows that 30 and 150 day-old rats treated with leptin dur-
ing lactation present higher AC/TC ratio and BMI compared to their re-
spective controls. Although this ratio is not an accurate as marker of
increased body weight and obesity in rats, there is a positive correlation
between BMI with carcass fat, being obesity easily estimated from this
anthropometrical parameter in rats [4]. A positive correlation between
BMI with serum triacylglycerol, dyslipidemic proﬁle and oxidative
Table 1
Anthropometrical and functional (hemodynamic, echocardiography and electrocardiography) data obtained from rats that received saline (Control— Leptin naive) or leptin (Leptin) dur-
ing lactation at 30 and 150 days of age.
Variables 30 days of age 150 days of age
Control Leptin Control Leptin
n = 10 n = 11 n = 11 n = 15
AC/TC 1.126 ± 0.010 1.174 ± 0.013⁎ 1.115 ± 0.008 1.145 ± 0.011⁎
BMI (g/cm2) 0.460 ± 0.008 0.482 ± 0.006⁎ 0.746 ± 0.006 0.784 ± 0.010⁎
n = 10 n = 12 n = 8 n = 12
SBP (mm Hg) 118.3 ± 0.3 118.8 ± 0.5 118.6 ± 0.6 118.9 ± 0.4
n = 12 n = 12 n = 11 n = 15
LVEF (%) 93.83 ± 0.87 91.77 ± 1.18 88.06 ± 1.65 81.32 ± 2.29⁎
LA/Ao ratio 1.020 ± 0.006 1.048 ± 0.011⁎ 1.020 ± 0.017 1.256 ± 0.046⁎
IVSd (cm) 0.133 ± 0.003 0.144 ± 0.004⁎ 0.206 ± 0.005 0.203 ± 0.007
IVSs (cm) 0.220 ± 0.008 0.233 ± 0.008 0.339 ± 0.011 0.318 ± 0.011
LVPWd (cm) 0.136 ± 0.003 0.149 ± 0.005⁎ 0.215 ± 0.007 0.212 ± 0.007
LVPWs (cm) 0.226 ± 0.008 0.236 ± 0.009 0.325 ± 0.009 0.317 ± 0.009
LVIDd (cm) 0.390 ± 0.013 0.384 ± 0.018 0.681 ± 0.020 0.763 ± 0.028⁎
LVIDs (cm) 0.138 ± 0.004 0.153 ± 0.007 0.297 ± 0.019 0.376 ± 0.025⁎
RWT (cm) 0.704 ± 0.014 0.787 ± 0.032⁎ 0.623 ± 0.023 0.566 ± 0.031
LV mass (g) 0.775 ± 0.011 0.833 ± 0.025⁎ 1.44 ± 0.04 1.65 ± 0.08⁎
Mitral DT (ms) 61.67 ± 2.21 66.67 ± 2.43 85.82 ± 3.19 77.47 ± 2.39⁎
n = 8 n = 9 n = 5 n = 9
HR (BPM) 410.2 ± 5.9 414.8 ± 11.7 376.6 ± 3.3 438.2 ± 9.8⁎
RR (s) 0.142 ± 0.005 0.142 ± 0.005 0.156 ± 0.003 0.137 ± 0.003⁎
QRS (s) 0.0162 ± 0.0002 0.0161 ± 0.0002 0.0126 ± 0.0014 0.0146 ± 0.0003
PR (s) 0.045 ± 0.001 0.045 ± 0.001 0.046 ± 0.001 0.046 ± 0.001
QT (s) 0.053 ± 0.002 0.053 ± 0.002 0.047 ± 0.005 0.054 ± 0.004
QTc (s) 0.141 ± 0.006 0.142 ± 0.005 0.120 ± 0.014 0.145 ± 0.013
AC/TC— abdominal circumference/thoracic circumference ratio; BMI— bodymass index; SBP— systolic blood pressure; LVEF— left ventricle ejection fraction; LA/Ao ratio— left-atrium-
to-aorta ratio; IVS— intraventricular septum thickness; LVPW— left ventricle posterior wall thickness; LVID— left ventricle internal diameter; RWT— relative wall thickness; LVmass—
left ventricle mass; Mitral DT—mitral deceleration time; d — diastole; s — systole; HR — heart rate.
⁎ P b 0.05— Leptin vs Control.
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rats submitted to neonatal leptin treatment.
Although SBP are not different between rats that received saline or
leptin during lactation, data from echocardiographic studies (Table 1)
show that LA/Ao ratio and LV mass are raise in rats treated with leptin
during lactation. The observed left atrium enlargement is considered
useful as a quick bedside technique to screen for cardiac disease [8]. In-
creased LV mass can be related to either concentric or eccentric hyper-
trophy, depending on the RWT. So 30 day-old rats treated with leptin
during lactation presents a concentric hypertrophy while 150 day-old
rats of the same group presents an eccentric hypertrophy. These data
are suggestive of cardiac dysfunction [7].
The abnormality of the left ventricle geometry observed in young
rats treated with leptin is related to an increase of IVS and LVPW in
diastole while the abnormality of the left ventricle geometryFig. 1. (A) Distance preformed, (B) time spent and (C) speeddeveloped by rats that received sali
(n = 11–15) and 150 days (n = 5) of age. *P b 0.5.observed in adult rats treated with leptin is related to an increase
of LVID [7].
LVEF and Mitral DT were diminished in the older rats treated with
leptin compared to control (Table 1). Although diastolic dysfunction is
not uncommon in patients with normal wall thickness, left ventricular
hypertrophy is among the important reasons for it. In patients with di-
astolic heart failure, concentric hypertrophy (as seen in young rats
treated with leptin) can be observed. In contrast, eccentric hypertrophy
is usually present in patients with depressed LVEF that also present nor-
mal blood pressure (as seen in adult rats treated with leptin). In addi-
tion, patients with impaired left ventricle relaxation ﬁlling are the
least symptomatic, while a short Mitral DT, as seen in 150 day-old
rats, characterizes advanced diastolic dysfunction, increased LA pres-
sure andworse functional class. A restrictive ﬁlling pattern is associated
with a poor prognosis, especially if it persists after preload reduction [9].ne (Control— Leptinna ve— gray bars) or leptin (Leptin— black bars) during location at 30
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and RR interval diminished in adult rats submitted to leptin treatment,
suggesting the raise of sympathetic activity. Our data support the idea
that imprinting factors which increase leptin and catecholamine levels
during the neonatal period could be involved in development of adult
chronic diseases [3].
Fig. 1 shows that distance performed, time spent and speed devel-
oped were lower both in young and adult rats treated with leptin. This
data show that cardio-respiratory capacity is diminished in these rats
[7].
Thus, our data suggest that the signs of cardiac dysfunction
displayed by our experimental model in youth is compatible with dia-
stolic heart failure (stage B), evolving to systolic dysfunction in adult-
hood [7,9,10].
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